Potassium Phosphates Solution, Concentrate
NDC Package 80830-1691-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Potassium Phosphates (potassium phosphate, monobasic potassium phosphate, dibasic injection,) solution is potassium phosphates injection is indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. This formulation utilizes a solution, concentrate delivery system. Marketed by Amneal Pharmaceuticals Private Limited, this product is identified by NDC 80830-1691 and is authorized under FDA application ANDA216344.

Identification & Billing

NDC Package Code
80830-1691-2
Package Description
10 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-1)
Product Code
80830-1691
11-Digit Billing Format
80830169102
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1928569 - potassium phosphates (phosphorus 45 MMOL / potassium 66 MEQ) in 15 ML Injection
  • RxCUI: 1928569 - 15 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection
  • RxCUI: 1928569 - 15 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection
  • RxCUI: 1928569 - 15 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection
  • RxCUI: 1928569 - phosphorus 45 MMOL / potassium 66 MEQ per 15 ML Injection

Clinical Specifications

Proprietary Name
Potassium Phosphates
Non-Proprietary Name
Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic Injection,
Substance Name
Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic
Dosage Form
Solution, Concentrate - A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its nonactive parts.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Potassium phosphates injection is indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated.

Regulatory & Marketing

Labeler Name
Amneal Pharmaceuticals Private Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA216344
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-09-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (80830-1691). Click a package code to view its specific billing and regulatory data.

80830-1691-5
25 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-1)
80830-1691-7
10 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-6)
80830-1691-9
10 VIAL, SINGLE-DOSE in 1 CARTON / 15 mL in 1 VIAL, SINGLE-DOSE (80830-1691-3)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 80830-1691-2 identifies a specific commercial package of 10 vial, single-dose in 1 carton / 15 ml in 1 vial, single-dose (80830-1691-1) of Potassium Phosphates, a human prescription drug labeled by Amneal Pharmaceuticals Private Limited. This solution, concentrate is formulated for intravenous use and contains potassium phosphate, dibasic; potassium phosphate, monobasic as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amneal Pharmaceuticals Private Limited on July 09, 2025. The current certification is valid through December 31, 2027.

How is this Amneal Pharmaceuticals Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 80830169102. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
80830-1691-2
11-Digit CMS (5-4-2)
80830-1691-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.